Detail page

Knowledge Web

Person

Rienk Offringa

Arzt

Name	Rienk Offringa
Place	Heidelberg (Wirkungsort) Deutschland
Academic degree	Prof. Dr. med.
Profession	Arzt (characteristic profession)
Variant	R. Offringa
Related	Klinikum Heidelberg
Further information	Sektionsleiter Sektion Pankreaskarzinomforschung, Chirurgische Klinik, Universitätsklinikum Heidelberg
Record type	Person
GND-Identifier	1066807485
Record ID	1066807485
Involved in show all Prediction of tumor-reactive T cell receptors from scRNA-seq data for personalized T cell therapy Characterization of tumor-infiltrating CD8+ T cells towards clinical application Dissection of the tumor-reactive and bystander T-cell repertoires at the single-cell level in an orthotopic mouse model for pancreatic cancer Preclinical evaluation of the multikinase inhibitor regorafenib for the treatment of pancreatic cancer Timed Ang2-targeted therapy identifies the Angiopoietin–tie pathway as key regulator of fatal lymphogenous metastasis Photon versus carbon ion irradiation: immunomodulatory effects exerted on murine tumor cell lines Identification of synergistic combinations of targeted cytostatic drugs and immunostimulatory antibodies in preclinical models Sensitization of tumor cells for T cell mediated eradication through targeted delivery of virus-derived immunogenic peptide epitopes A high‐throughput RNA i screen for detection of immune‐checkpoint molecules that mediate tumor resistance to cytotoxic T lymphocytes

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Rienk Offringa

Prediction of tumor-reactive T cell receptors from scRNA-seq data for personalized T cell therapy

Characterization of tumor-infiltrating CD8+ T cells towards clinical application

Dissection of the tumor-reactive and bystander T-cell repertoires at the single-cell level in an orthotopic mouse model for pancreatic cancer

Preclinical evaluation of the multikinase inhibitor regorafenib for the treatment of pancreatic cancer

Timed Ang2-targeted therapy identifies the Angiopoietin–tie pathway as key regulator of fatal lymphogenous metastasis

Photon versus carbon ion irradiation: immunomodulatory effects exerted on murine tumor cell lines

Identification of synergistic combinations of targeted cytostatic drugs and immunostimulatory antibodies in preclinical models

Sensitization of tumor cells for T cell mediated eradication through targeted delivery of virus-derived immunogenic peptide epitopes

A high‐throughput RNA i screen for detection of immune‐checkpoint molecules that mediate tumor resistance to cytotoxic T lymphocytes